Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Clinical trial NCT02445872 · UNKNOWN

Trial details

NCT number: NCT02445872
Sponsor: Zhejiang University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting Lung Cancer

Start date: 2015-12-01
Primary completion: 2016-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.